221 related articles for article (PubMed ID: 27566684)
1. Brain perfusion alterations in depressed patients with Parkinson's disease.
Kim YD; Jeong HS; Song IU; Chung YA; Namgung E; Kim YD
Ann Nucl Med; 2016 Dec; 30(10):731-737. PubMed ID: 27566684
[TBL] [Abstract][Full Text] [Related]
2. Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD.
Fregni F; Ono CR; Santos CM; Bermpohl F; Buchpiguel C; Barbosa ER; Marcolin MA; Pascual-Leone A; Valente KD
Neurology; 2006 Jun; 66(11):1629-37. PubMed ID: 16769932
[TBL] [Abstract][Full Text] [Related]
3. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
[TBL] [Abstract][Full Text] [Related]
4. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P
Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
[TBL] [Abstract][Full Text] [Related]
5. The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment.
Imamura K; Okayasu N; Nagatsu T
Acta Neurol Scand; 2011 Jul; 124(1):28-39. PubMed ID: 20880269
[TBL] [Abstract][Full Text] [Related]
6. Brain regions associated with cognitive impairment in patients with Parkinson disease: quantitative analysis of cerebral blood flow using 123I iodoamphetamine SPECT.
Hattori N; Yabe I; Hirata K; Shiga T; Sakushima K; Tsuji-Akimoto S; Sasaki H; Tamaki N
Clin Nucl Med; 2013 May; 38(5):315-20. PubMed ID: 23478846
[TBL] [Abstract][Full Text] [Related]
7. The value of brain perfusion SPECT for differentiation between mildly symptomatic idiopathic Parkinson's disease and the Parkinson variant of multiple system atrophy.
Song IU; Yoo I; Chung YA; Jeong J
Nucl Med Commun; 2015 Oct; 36(10):1049-54. PubMed ID: 26087241
[TBL] [Abstract][Full Text] [Related]
8. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations.
Oishi N; Udaka F; Kameyama M; Sawamoto N; Hashikawa K; Fukuyama H
Neurology; 2005 Dec; 65(11):1708-15. PubMed ID: 16344511
[TBL] [Abstract][Full Text] [Related]
9. Correlated regions of cerebral blood flow with clinical parameters in Parkinson's disease; comparison using 'Anatomy' and 'Talairach Daemon' software.
Yoon HJ; Cheon SM; Jeong YJ; Kang DY
Ann Nucl Med; 2012 Feb; 26(2):164-74. PubMed ID: 22042522
[TBL] [Abstract][Full Text] [Related]
10. Abnormal functional connectivity of the amygdala is associated with depression in Parkinson's disease.
Hu X; Song X; Yuan Y; Li E; Liu J; Liu W; Liu Y
Mov Disord; 2015 Feb; 30(2):238-44. PubMed ID: 25545969
[TBL] [Abstract][Full Text] [Related]
11. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.
Wakamori T; Agari T; Yasuhara T; Kameda M; Kondo A; Shinko A; Sasada S; Sasaki T; Furuta T; Date I
Parkinsonism Relat Disord; 2014 Apr; 20(4):415-20. PubMed ID: 24467818
[TBL] [Abstract][Full Text] [Related]
12. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease.
Sestini S; Scotto di Luzio A; Ammannati F; De Cristofaro MT; Passeri A; Martini S; Pupi A
J Nucl Med; 2002 Jun; 43(6):725-32. PubMed ID: 12050315
[TBL] [Abstract][Full Text] [Related]
13. Relationship between regional cerebral blood flow and separate symptom clusters of major depression: a single photon emission computed tomography study using statistical parametric mapping.
Périco CA; Skaf CR; Yamada A; Duran F; Buchpiguel CA; Castro CC; Soares JC; Busatto GF
Neurosci Lett; 2005 Aug; 384(3):265-70. PubMed ID: 15921853
[TBL] [Abstract][Full Text] [Related]
14. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease.
Imon Y; Matsuda H; Ogawa M; Kogure D; Sunohara N
J Nucl Med; 1999 Oct; 40(10):1583-9. PubMed ID: 10520695
[TBL] [Abstract][Full Text] [Related]
15. Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction.
Hsu JL; Jung TP; Hsu CY; Hsu WC; Chen YK; Duann JR; Wang HC; Makeig S
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1458-66. PubMed ID: 17437108
[TBL] [Abstract][Full Text] [Related]
16. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study.
Feldmann A; Illes Z; Kosztolanyi P; Illes E; Mike A; Kover F; Balas I; Kovacs N; Nagy F
Mov Disord; 2008 Jan; 23(1):42-6. PubMed ID: 17973326
[TBL] [Abstract][Full Text] [Related]
17. A SPECT study of apathy in Alzheimer's disease.
Lanctôt KL; Moosa S; Herrmann N; Leibovitch FS; Rothenburg L; Cotter A; Black SE
Dement Geriatr Cogn Disord; 2007; 24(1):65-72. PubMed ID: 17565215
[TBL] [Abstract][Full Text] [Related]
18. rCBF SPECT in Parkinson's disease patients with mental dysfunction.
Bissessur S; Tissingh G; Wolters EC; Scheltens P
J Neural Transm Suppl; 1997; 50():25-30. PubMed ID: 9120420
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia.
Osaki Y; Morita Y; Fukumoto M; Akagi N; Yoshida S; Doi Y
Mov Disord; 2005 Aug; 20(8):999-1005. PubMed ID: 15806567
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Tamura S; Nakazato M; Yamashita S; Arita H; Nishii R; Kawai K
Ann Nucl Med; 2008 Aug; 22(7):557-64. PubMed ID: 18756357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
